Skip to main content
SAMSUNG PHARMACEUTICAL.CO.,Ltd. logo

SAMSUNG PHARMACEUTICAL.CO.,Ltd. — Investor Relations & Filings

Ticker · 001360 ISIN · KR7001360007 KO Manufacturing
Open in API
Filings indexed 196 across all filing types
Latest filing 2024-02-07 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 001360

About SAMSUNG PHARMACEUTICAL.CO.,Ltd.

http://www.sspharm.com/

Samsung Pharmaceutical Co., Ltd. is a company engaged in the research, development, manufacturing, and sale of pharmaceutical products. Its portfolio includes a range of medications, such as antibiotics and liver treatments, with a research focus on therapeutic areas like neoplasms. In addition to its core pharmaceutical operations, the company is also involved in the bio business and the sale of health foods.

Recent filings

Filing Released Lang Actions
유상증자신주발행가액(안내공시)
Share Issue/Capital Change Classification · 100% confidence The document is an official announcement from Samsung Pharmaceutical regarding the 'fixed issue price' for a capital increase (rights offering). It details the calculation methodology for the new share price and confirms the final price per share. This falls under the category of capital structure changes and financing activities, specifically related to share issuance.
2024-02-07 Korean
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) from Samsung Pharmaceutical Co., Ltd. regarding a 'Capital Increase Decision' (유상증자결정). It details the correction of the issuance price for new shares, including specific pricing formulas, subscription dates, and allocation methods. This falls under the category of announcements regarding new share issues and capital structure changes, which is classified as 'SHA' (Share Issue/Capital Change).
2024-02-07 Korean
[발행조건확정]증권신고서(지분증권)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Securities Registration Statement' (증권신고서) filed with the Financial Services Commission (금융위원회) in South Korea. It details the finalization of the issuance price for a capital increase (rights offering with general public offering for unsubscribed shares). Since this document specifically relates to the issuance of new shares and changes in capital structure, it falls under the 'Share Issue/Capital Change' category.
2024-02-07 Korean
[기재정정]투자설명서
Capital/Financing Update Classification · 98% confidence The document is a 'Correction Report' (정정신고) for an 'Investment Prospectus' (투자설명서) filed by Samsung Pharmaceutical Co., Ltd. It details changes to the offering price and related financial figures for a capital increase (rights offering). In the context of financial filings, a prospectus or its amendment is a primary document related to capital raising activities. According to the provided definitions, 'CAP' (Capital/Financing Update) is the most appropriate category for documents detailing fundraising and capital structure changes, including prospectuses and their amendments.
2024-02-07 Korean
투자판단관련주요경영사항
Regulatory Filings Classification · 100% confidence The document is a formal regulatory filing from Samsung Pharmaceutical regarding a change in their Phase 3 clinical trial application for an Alzheimer's drug (GV1001). It details the clinical trial design, the reason for the change (licensing agreement and protocol adjustments), and the submission date to the Ministry of Food and Drug Safety (MFDS). Since this is a specific regulatory disclosure of a material business event (clinical trial status) that does not fit into financial reporting, dividend, or governance categories, it is classified as a general regulatory filing.
2024-01-05 Korean
유상증자신주발행가액(안내공시)
Share Issue/Capital Change Classification · 100% confidence The document is an official announcement from Samsung Pharmaceutical regarding the 'New Share Issuance Price' (유상증자 신주발행가액) for a capital increase (rights offering). It details the calculation methodology for the issuance price and provides a timeline for the final determination. This falls under the category of capital structure changes and financing updates, specifically related to share issuance.
2024-01-03 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.